As expected, we found that inhibition of CARM1 enzymatic activity by EZM2302 significantly inhibited the proliferative and colony-forming abilities of NSCLC PC9 and HCC827 cells (Figure 4D and 4E; **P < 0.01). Here, CARM1 is linked to non-small cell lung carcinoma.